Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liquid Biopsy as a Non-invasive Tool for the Diagnosis of NASH and Liver Fibrosis

NCT04677101 is registered in ClinicalTrials.gov with Catholic University of the Sacred Heart as lead sponsor.

NCT NCT04677101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04677101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liquid Biopsy as a Non-invasive Tool for the Diagnosis of NASH and Liver Fibrosis
Lead sponsor
Catholic University of the Sacred Heart
Phase
Observational
Overall status
Completed
Start date
December 16, 2020
Completion date
April 16, 2021
Enrollment
150 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

liver fibroses, nash - nonalcoholic steatohepatitis